Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sunmax Biotechnology CoROCO:4728 91 Interest Coverage is 335.31 as of Jun. 2026, which is 115% above its 10-year median of 155.74. GuruFocus rates ROCO:4728 with a GF Score™ of 91/100 and a GF Value™ of NT$405.40 (Fairly Valued). The stock has 2 warning signs investors should review. Among 378 Biotechnology companies, Sunmax Biotechnology Co ranks better than 56.08% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Sunmax Biotechnology Co's
Operating Income
for the
three
months ended in Jun. 2026 was NT$329 Mil. Sunmax Biotechnology Co's Interest Expense for the
three
months ended in Jun. 2026 was NT$-1 Mil.
Sunmax Biotechnology Co's interest coverage for the quarter that ended in Jun. 2026 was 335.31.
The higher the ratio, the stronger the company's financial strength is.
Good Sign:
Ben Graham prefers companies' interest coverage to be at least 5. Sunmax Biotechnology Co Ltd has enough cash to cover all of its debt. Its financial situation is stable.
The historical rank and industry rank for Sunmax Biotechnology Co's Interest Coverage or its related term are showing as below:
ROCO:4728'
s Interest Coverage Range Over the Past 10 Years
Min: 64.69 Med: 155.74 Max: No Debt
Current: 247.52
ROCO:4728's Interest Coverage is ranked better than 56.08% of 378
companies
in the Biotechnology industry
Industry Median: 105.09
vs ROCO:4728: 247.52
Sunmax Biotechnology Co (ROCO:4728) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Sunmax Biotechnology Co Interest Coverage Related Terms
Sunmax Biotechnology Co Interest Coverage Historical Data
* Premium members only.
The historical data trend for Sunmax Biotechnology Co's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
ROCO:4728 vs VRTX, REGN, RVMD: Interest Coverage Comparison
For the Biotechnology subindustry, Sunmax Biotechnology Co's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sunmax Biotechnology Co Interest Coverage vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Sunmax Biotechnology Co's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Sunmax Biotechnology Co's Interest Coverage falls into.
Sunmax Biotechnology Co Interest Coverage Calculation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sunmax Biotechnology Co (ROCO:4728) has a Interest Coverage of 335.31 as of Jun. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Sunmax Biotechnology Co and its competitors. This is 115% above median its historical median of 155.74. Over the past decade, Sunmax Biotechnology Co's Interest Coverage has ranged from 64.69 to 10,000.00. According to the industry distribution chart, Sunmax Biotechnology Co ranks #166 out of 378 companies in the Biotechnology industry, placing it in the top 43.9%.
Is Sunmax Biotechnology Co's Interest Coverage too high?
Sunmax Biotechnology Co's current Interest Coverage of 335.31 is 115% above median its 10-year median of 155.74. Over the past 10 years, this metric has ranged from a low of 64.69 to a high of 10,000.00. The Biotechnology industry median Interest Coverage is 105.09. Sunmax Biotechnology Co's value of 335.31 is 219.1% above this industry median. Based on the distribution chart, Sunmax Biotechnology Co ranks #166 out of 378 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Sunmax Biotechnology Co has a GF Score™ of 91/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sunmax Biotechnology Co's Interest Coverage compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Sunmax Biotechnology Co ranks #166 out of 378 companies for Interest Coverage. This puts Sunmax Biotechnology Co in the upper half of its industry. The industry median Interest Coverage is 105.09. Sunmax Biotechnology Co's value of 335.31 is 219.1% above this benchmark. Historically, Sunmax Biotechnology Co's own Interest Coverage has ranged from 64.69 to 10,000.00 over the past decade. While the company's 10-year median is 155.74 vs. the industry median of 105.09, Sunmax Biotechnology Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Biotechnology company?
The median Interest Coverage among Biotechnology companies is 105.09, based on 378 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sunmax Biotechnology Co's current Interest Coverage of 335.31 is 219.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Sunmax Biotechnology Co and its competitors. For the Biotechnology industry, the median Interest Coverage is 105.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sunmax Biotechnology Co's current Interest Coverage is 335.31, which is 115% above median its own 10-year median of 155.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sunmax Biotechnology Co stock overvalued right now?
Based on GuruFocus' analysis, Sunmax Biotechnology Co (ROCO:4728) is currently considered Fairly Valued. The stock's GF Value™ is NT$405.40, compared to a current price of NT$400.00 — trading 1.3% below its estimated fair value. The current Interest Coverage is 335.31, which is 115% above median its 10-year median of 155.74 and 219.1% above the Biotechnology industry median of 105.09. Sunmax Biotechnology Co's overall GF Score™ is 91/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Sunmax Biotechnology Co (ROCO:4728), the current Interest Coverage is 335.31 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sunmax Biotechnology Co (ROCO:4728) Overvalued in 2026?
Based on GuruFocus' analysis, Sunmax Biotechnology Co stock appears to be undervalued.
The current stock price of NT$400.00 is trading 1.3% below its estimated GF Value™ of NT$405.40.
GuruFocus considers Sunmax Biotechnology Co to be Fairly Valued.
Key valuation signals for ROCO:4728:
Interest Coverage: 335.31 (115% above median its 10-year median of 155.74)
GF Value™: NT$405.40 vs. price of NT$400.00 (1.3% below fair value)
Industry Position: 219.1% above the Biotechnology median (#166 of 378)
No single metric tells the full story. See the ROCO:4728 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sunmax Biotechnology Co Ltd is a biomedical company in Taiwan. It is engaged in the development, manufacturing, and commercialization of Sunmax medical devices and bio-surgical products. Additionally, it also researches, develops, manufactures and sales biomedical material grade collagen and related products. The company's products include medical products, biomedical materials, and porcine collagen skin care products.
91GF Score
Get the complete analysis for ROCO:4728
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4728 has been successfully added to your 
